Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How do you manage a prostate cancer patient with pelvic lymphadenopathy and a single enlarged PSMA PET+ gastrohepatic node?
Do you consider radiation therapy in such a case?
Answer from: Radiation Oncologist at Community Practice
I would treat it as oligometastatic, starting with ADT/ARPI and use metastasis-directed therapy and pelvic radiation.
Sign In
or
Register
to read more
31982
Related Questions
How would you approach radiation for node-positive prostate cancer in a patient with an aortic and/or common iliac arterial aneurysm not meeting criteria for surgical repair?
What are the treatment options for a patient with unfavorable intermediate risk PCa who desires future child bearing?
What are your top takeaways in GU Cancers from ESMO 2025?
Would you add whole-pelvis radiation as MDT (metastasis-directed therapy) in a patient with 1 pelvic node and 2 osseous metastatic sites for castrate-resistant prostate cancer?
In what situations would you utilize radiation therapy for management of high grade urothelial carcinoma of the prostate?
Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?
What is the rationale for the recent change in the NCCN criteria for very high risk prostate cancer?
Would you ever re-irradiate the groin/inguinal region?
Do you utilize daily enemas for patients undergoing prostate SBRT?
What time frame, number of PSAs, and calculator do you use for calculating PSA doubling times?